Industry news that matters to you.  Learn more

Metabolon Launches Strategic Outsourcing Programs Focused on Disease Metabolism

Metabolon, Inc., a diagnostics and services company offering the industry’s leading biochemical profiling technology, announces the launch of its Disease Metabolism Strategic Outsourcing Program.

CLC bio to Develop Bioinformatics Tools for Prostate Cancer Biomarker Project

CLC bio is participating in a $4 million Danish collaboration focused on the identification and validation of biomarkers of prostate cancer risk and aggressiveness. Headed by the Department of Molecular Medicine at Aarhus University Hospital, CLC bio will develop bioinformatics tools that will allow the integrated analysis of microarray and next-generation sequencing data for biomarker identification.

Sophic to Use $750K NCI Grant to Complete Cancer Biomarker Knowledgebase

Sophic Systems Alliance has snagged a two-year, Phase II $750,000 Small Business Innovation Research Grant from the National Cancer Institute that will fund the continued development of SCan-MarK — a knowledgebase that the company is intending as a one-stop shop for cancer biomarker information for oncologists, drug developers, and cancer researchers.